Genes regulated in ovarian cancer as prognostic and therapeutic targets

Details for Australian Patent Application No. 2004256182 (hide)

Owner Novartis AG

Inventors Lavedan, Christian Nicolas

Agent Davies Collison Cave

Pub. Number AU-A-2004256182

PCT Pub. Number WO2005/005661

Priority 60/484,465 02.07.03 US

Filing date 1 July 2004

Wipo publication date 20 January 2005

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2005/005661 Priority application(s): WO2005/005661

26 June 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004256204-Process for preparing purified fatty acids

2004256178-Method for the detection of cytosine methylations in DNA by means of cytidine deaminases